Literature DB >> 24155538

Treatment of refractory keloids with pulsed dye laser alone and with rotational pulsed dye laser and intralesional corticosteroids: A retrospective case series.

S Stephanides1, S Rai, Pj August, Je Ferguson, V Madan.   

Abstract

BACKGROUND AND AIMS: The limited available effective treatments make the management of keloids challenging. Intralesional triamcinolone and pulsed dye laser have been used for the treatment of keloids. We sought to assess the efficacy of a treatment regime using rotational intralesional triamcinolone and pulsed dye laser in the management of keloids. Materials (Subjects) and
Methods: Case notes and photographic records of 99 patients with keloids treated with pulsed dye laser (PDL) alone or rotational PDL and intralesional triamcinolone (ILT) at our centre between 2005 and 2010 were reviewed. Patients with raised, erythematous and/or symptomatic keloids unresponsive to ILT alone (usually 6 treatments) are referred for consideration of PDL. Patients are offered repeated rotational treatments of three PDL (4-15 J/cm(2), 7 mm spot, 1.5 msec pulse duration, 595 nm wavelength, DCD, 30 msec spray: 20 msec delay; spaced at 6-8 weeks intervals) followed by one ILT (10 mg or 40 mg/dl). ILT-treated flat but erythematous and/or symptomatic keloids are treated with PDL alone at 6-8 week intervals. Response after each laser treatment is documented as a percentage improvement from baseline. Based on the improvement in redness, thickness and pruritus the operator classified the response to treatment as mild (0-49%), moderate (50-75%) or excellent (>75%). Patients are reviewed at 6 months following last treatment. A patient satisfaction questionnaire was also sent out to all patients who received treatments between 2005 and 2010 and this was compared with the information gathered from the notes.
RESULTS: Of the 99 patients, 58 were women and 41 were men and most were Caucasian (n=84). A total of 755 keloids were treated. The average number of PDL treatments to achieve a moderate-excellent result was 14 in male and 12 in females. Moderate-excellent improvement was seen in 76% patients. The average number of ILT required to achieve a moderate-excellent result was 5 in males and 4 in females. All patients were sent a satisfaction questionnaire and 33 responses were received wherein patients reported an average of 70% improvement in the redness and thickness of the keloids. Localised cutaneous atrophy, self-limiting erythema and injection site discomfort were noted in 3 female patients whilst no side-effects noted in the male cohort.
CONCLUSIONS: Pulsed dye laser with or without intralesional triamcinolone is a moderately effective treatment of keloid scars with a very good side-effect profile and high patient satisfaction.

Entities:  

Keywords:  Keloids; Laser; Pulsed dye laser; Scars; Triamcinolone

Year:  2011        PMID: 24155538      PMCID: PMC3799037          DOI: 10.5978/islsm.12-or-01

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  23 in total

Review 1.  On the nature of hypertrophic scars and keloids: a review.

Authors:  F B Niessen; P H Spauwen; J Schalkwijk; M Kon
Journal:  Plast Reconstr Surg       Date:  1999-10       Impact factor: 4.730

2.  Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy.

Authors:  N A Chowdri; M Masarat; A Mattoo; M A Darzi
Journal:  Aust N Z J Surg       Date:  1999-09

3.  Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study.

Authors:  M A Darzi; N A Chowdri; S K Kaul; M Khan
Journal:  Br J Plast Surg       Date:  1992-07

Review 4.  Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations.

Authors:  Gérald J Prud'homme
Journal:  Lab Invest       Date:  2007-08-27       Impact factor: 5.662

5.  Ultrastructural characteristics of keloid fibroblasts.

Authors:  L Y Matsuoka; J Uitto; J Wortsman; R P Abergel; J Dietrich
Journal:  Am J Dermatopathol       Date:  1988-12       Impact factor: 1.533

6.  Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser.

Authors:  R P Abergel; R M Dwyer; C A Meeker; G Lask; A P Kelly; J Uitto
Journal:  Lasers Surg Med       Date:  1984       Impact factor: 4.025

7.  Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.

Authors:  Mandeep Singh; Brent A Williams; Bernard J Gersh; Robyn L McClelland; Kalon K L Ho; James T Willerson; William F Penny; Donald E Cutlip; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2006-01-03       Impact factor: 24.094

Review 8.  Genetics of keloid scarring.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Arch Dermatol Res       Date:  2010-02-04       Impact factor: 3.017

Review 9.  Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.

Authors:  Dolores Wolfram; Alexandar Tzankov; Petra Pülzl; Hildegunde Piza-Katzer
Journal:  Dermatol Surg       Date:  2009-02       Impact factor: 3.398

10.  Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts.

Authors:  H Yamada; S Tajima; T Nishikawa; S Murad; S R Pinnell
Journal:  J Biochem       Date:  1994-10       Impact factor: 3.387

View more
  3 in total

Review 1.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

Review 2.  Keloids: Current and emerging therapies.

Authors:  Nkemcho Ojeh; Ambadasu Bharatha; Uma Gaur; Andrew LeRoy Forde
Journal:  Scars Burn Heal       Date:  2020-08-10

3.  Efficacy and safety of laser combination therapy and laser alone therapy for keloid: a systematic review and meta-analysis.

Authors:  Jiahui Chen; Aiyue Chen; Jianhao Zhang; Feipeng Wang; Qiongfang Fang; Ziwei He; Xi Chen; Wancheng Ma; Fulan Hu
Journal:  Lasers Med Sci       Date:  2021-07-20       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.